An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: A randomized controlled trial (CVIM 4 study)

• Main Authors: Jackrapong Bruminhent, Chavachol Setthaudom, Pattaraphorn Phornkittikorn, Pongsathon Chaumdee, Somsak Prasongtanakij, Supanart Srisala, Kumthorn Malathum, Sarinya Boongird, Arkom Nongnuch, Montira Assanatham, Laor Nakgul, Nutaporn Sanmeema, Angsana Phuphuakrat, Sasisopin Kiertiburanakul
• 其他作者: Faculty of Medicine Ramathibodi Hospital, Mahidol University
• 格式: Article
• 出版: 2022
• 主題: Medicine
• 在線閱讀: https://repository.li.mahidol.ac.th/handle/123456789/74912

Immunogenicity following an additional dose of Coronavirus disease 2019 (COVID-19) vaccine was investigated in an extended primary series among kidney transplant (KT) recipients. Eighty-five KT participants were randomized to receive either an mRNA (M group; n = 43) or viral vector (V group; n = 42)...